Pakhsh Alborz Company
Pakhsh Alborz Company Public Joint Stock Company is a Tehran-based, Iran Fara Bourse-listed distributor within the Alborz Investment Company group. It supplies pharmaceuticals, controlled medicines, medical equipment, consumer-health products and FMCG through a nationwide network of warehouses and distribution centres. The company is relevant to healthcare suppliers and investors assessing national route-to-market capacity, regulated logistics and distribution infrastructure in Iran.
Operations & footprint
Products and services
Pakhsh Alborz Company distributes pharmaceuticals, medical equipment, consumer health products, food products, detergents, hygienic goods, narcotic and controlled medicines, cold-chain items, and related healthcare and FMCG products. Its activity includes nationwide warehousing, branch operations, pharmacy and healthcare-center supply, consumer-goods distribution, GSP and GDP-compliant logistics, cold-chain handling, order fulfillment, and supplier-to-retail distribution services.
Operations and assets
The network comprised 27 distribution centres nationwide as of 2023. Assets allocated by Alborz Investment Company for Pakhsh Alborz included 200,000 square metres of land and 90,000 square metres of warehouse space. Operations include cold-chain handling and licensed nationwide distribution of pharmaceuticals, foodstuffs, detergents and controlled medicines.
Geographic footprint
Headquartered in Tehran with 27 distribution centres across Iran as of 2023.
Ownership & group structure
Ownership
Alborz Investment Company held 48% as of 2 September 2023.
Parent company
Alborz Investment Company (شرکت سرمایه گذاری البرز).
Commercial and investment relevance
Pakhsh Alborz is relevant for investors assessing Iran's pharmaceutical distribution sector, cold-chain logistics, pharmacy coverage, medical-equipment distribution, consumer-health supply, FMCG distribution, and working-capital pressure in regulated healthcare markets. It can support analysis of medicine shortages, receivables from pharmacies and institutions, distributor margins, supplier concentration, inventory risk, and the financial impact of inflation and delayed payments. Due diligence should review updated Codal disclosures, IFB trading status, warehouse and branch network, supplier mix, controlled-drug handling, cold-chain quality, customer concentration, receivables aging, financing costs, regulatory compliance, and exposure to currency or import restrictions. Pakhsh Alborz provides suppliers with a national distribution route into pharmacies, healthcare centres and consumer retail channels. Its ability to handle cold-chain and controlled medicines makes it particularly relevant for regulated healthcare-product distribution.
Constraints, risk & compliance
Key risks and constraints
Operations depend on maintaining licences and quality controls for pharmaceutical, controlled-medicine and cold-chain distribution. The planned expansion of distribution infrastructure, including an Ahvaz distribution centre, creates execution and capital-deployment requirements.
Need more than a public profile?
Ask Hormuz to investigate, verify or act locally around Pakhsh Alborz Company. Tell us exactly what you need.
Connected Intelligence
Relevant geography, industry, market and execution context for this profile.
Frequently asked questions
Direct answers to the questions most likely to arise when reviewing this profile.
What does Pakhsh Alborz distribute?
Pakhsh Alborz distributes pharmaceuticals, controlled medicines, medical equipment, consumer-health products, food, detergents and hygienic goods.
Where does Pakhsh Alborz operate?
The company is headquartered in Tehran and operated 27 distribution centres across Iran as of 2023.
Who owns Pakhsh Alborz?
Pakhsh Alborz is part of the Alborz Investment Company group. Alborz Investment Company held 48% of the company as of 2 September 2023.
Is Pakhsh Alborz listed?
Yes. Pakhsh Alborz is a public joint-stock company listed on Iran Fara Bourse under the ticker پخش.